161 related articles for article (PubMed ID: 29569918)
1. Sialyltransferase-Based Chemoenzymatic Histology for the Detection of N- and O-Glycans.
Lopez Aguilar A; Meng L; Hou X; Li W; Moremen KW; Wu P
Bioconjug Chem; 2018 Apr; 29(4):1231-1239. PubMed ID: 29569918
[TBL] [Abstract][Full Text] [Related]
2. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
3. Majority of alpha2,6-sialylated glycans in the adult mouse brain exist in O-glycans: SALSA-MS analysis for knockout mice of alpha2,6-sialyltransferase genes.
Ohmi Y; Nishikaze T; Kitaura Y; Ito T; Yamamoto S; Sugiyama F; Matsuyama M; Takahashi Y; Takeda A; Kawahara T; Okajima T; Furukawa K; Furukawa K
Glycobiology; 2021 Jun; 31(5):557-570. PubMed ID: 33242079
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an O-glycan sialylation system in brain. Characterization of a beta-galactoside alpha 2,3-sialyltransferase from rat brain regulating the expression of an alpha-N-acetylgalactosaminide alpha 2,6-sialyltransferase activity.
Baubichon-Cortay H; Broquet P; George P; Louisot P
Eur J Biochem; 1989 Jun; 182(2):257-65. PubMed ID: 2472271
[TBL] [Abstract][Full Text] [Related]
5. Selective Exo-Enzymatic Labeling Detects Increased Cell Surface Sialoglycoprotein Expression upon Megakaryocytic Differentiation.
Yu SH; Zhao P; Sun T; Gao Z; Moremen KW; Boons GJ; Wells L; Steet R
J Biol Chem; 2016 Feb; 291(8):3982-9. PubMed ID: 26733198
[TBL] [Abstract][Full Text] [Related]
6. Efficient chemoenzymatic synthesis of O-linked sialyl oligosaccharides.
Blixt O; Allin K; Pereira L; Datta A; Paulson JC
J Am Chem Soc; 2002 May; 124(20):5739-46. PubMed ID: 12010048
[TBL] [Abstract][Full Text] [Related]
7. Human B Cell Differentiation Is Characterized by Progressive Remodeling of O-Linked Glycans.
Giovannone N; Antonopoulos A; Liang J; Geddes Sweeney J; Kudelka MR; King SL; Lee GS; Cummings RD; Dell A; Barthel SR; Widlund HR; Haslam SM; Dimitroff CJ
Front Immunol; 2018; 9():2857. PubMed ID: 30619255
[TBL] [Abstract][Full Text] [Related]
8. Direct fluorescent glycan labeling with recombinant sialyltransferases.
Wu ZL; Person AD; Burton AJ; Singh R; Burroughs B; Fryxell D; Tatge TJ; Manning T; Wu G; Swift KAD; Kalabokis V
Glycobiology; 2019 Oct; 29(11):750-754. PubMed ID: 31361010
[TBL] [Abstract][Full Text] [Related]
9. A Chemoenzymatic Histology Method for O-GlcNAc Detection.
Aguilar AL; Hou X; Wen L; Wang PG; Wu P
Chembiochem; 2017 Dec; 18(24):2416-2421. PubMed ID: 29044951
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
J Proteome Res; 2012 Apr; 11(4):2609-18. PubMed ID: 22329400
[TBL] [Abstract][Full Text] [Related]
11. Comparison of α2,6-sialyltransferases for sialylation of therapeutic proteins.
Janesch B; Saxena H; Sim L; Wakarchuk WW
Glycobiology; 2019 Sep; 29(10):735-747. PubMed ID: 31281932
[TBL] [Abstract][Full Text] [Related]
12. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
13. Alteration of N-Glycan Profiles in Diabetic Retinopathy.
Inafuku S; Noda K; Amano M; Ohashi T; Yoshizawa C; Saito W; Murata M; Kanda A; Nishimura S; Ishida S
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5316-22. PubMed ID: 26258617
[TBL] [Abstract][Full Text] [Related]
14. Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
Mungul A; Cooper L; Brockhausen I; Ryder K; Mandel U; Clausen H; Rughetti A; Miles DW; Taylor-Papadimitriou J; Burchell JM
Int J Oncol; 2004 Oct; 25(4):937-43. PubMed ID: 15375543
[TBL] [Abstract][Full Text] [Related]
15. Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer.
Mereiter S; Magalhães A; Adamczyk B; Jin C; Almeida A; Drici L; Ibáñez-Vea M; Gomes C; Ferreira JA; Afonso LP; Santos LL; Larsen MR; Kolarich D; Karlsson NG; Reis CA
Biochim Biophys Acta; 2016 Aug; 1860(8):1795-808. PubMed ID: 26721331
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and expression of a sixth type of alpha 2,8-sialyltransferase (ST8Sia VI) that sialylates O-glycans.
Takashima S; Ishida HK; Inazu T; Ando T; Ishida H; Kiso M; Tsuji S; Tsujimoto M
J Biol Chem; 2002 Jul; 277(27):24030-8. PubMed ID: 11980897
[TBL] [Abstract][Full Text] [Related]
18. CHoMP: a chemoenzymatic histology method using clickable probes.
Rouhanifard SH; López-Aguilar A; Wu P
Chembiochem; 2014 Dec; 15(18):2667-73. PubMed ID: 25403986
[TBL] [Abstract][Full Text] [Related]
19. The polypeptide part of human chorionic gonadotrophin affects the kinetics of alpha 6-sialylation of its N-linked glycans but does not alter the branch specificity of CMP-NeuAc:Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase.
Nemansky M; Edzes HT; Wijnands RA; Van den Eijnden DH
Glycobiology; 1992 Apr; 2(2):109-17. PubMed ID: 1606356
[TBL] [Abstract][Full Text] [Related]
20. Mucin-type O-glycans in tears of normal subjects and patients with non-Sjögren's dry eye.
Guzman-Aranguez A; Mantelli F; Argüeso P
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4581-7. PubMed ID: 19407012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
